US 12377101
Combination therapies
granted A61KA61K31/497A61K31/519
Quick answer
US patent 12377101 (Combination therapies) held by Mirati Therapeutics, Inc. expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Mirati Therapeutics, Inc.
- Grant date
- Tue Aug 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/497, A61K31/519, A61K31/5355, A61K45/06